Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
10.99
+0.58 (5.57%)
At close: Jun 26, 2026, 4:00 PM EDT
10.99
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:31 PM EDT
Keros Therapeutics Employees
Keros Therapeutics had 87 employees as of March 31, 2026. The number of employees increased by 9 or 11.54% since the number was last reported on December 31, 2025.
Employees
87
Change
9
Growth
11.54%
Revenue / Employee
$381,402
Profits / Employee
-$978,678
Market Cap
217.51M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| Karyopharm Therapeutics | 228 |
| Codexis | 146 |
| Nkarta | 108 |
| Alector | 103 |
| Immunic | 95 |
| Camp4 Therapeutics | 48 |
| Q32 Bio | 22 |
KROS News
- 2 days ago - Keros Therapeutics Appoints Anne Prener to its Board of Directors - GlobeNewsWire
- 19 days ago - Keros Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 26 days ago - Keros Therapeutics Announces Participation at Goldman Sachs 47th Annual Global Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Keros Therapeutics reports Q1 EPS ($1.21), consensus (92c) - TheFly
- 6 weeks ago - Keros Therapeutics Reports Recent First Quarter 2026 Financial Results - GlobeNewsWire
- 6 weeks ago - Keros Therapeutics Earnings release: Q1 2026 - Filings
- 6 weeks ago - Keros Therapeutics Quarterly report: Q1 2026 - Filings
- 2 months ago - Keros Therapeutics Proxy statement: Proxy filing - Filings